These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. A multi-level model accounting for the effects of JAK2-STAT5 signal modulation in erythropoiesis. Lai X; Nikolov S; Wolkenhauer O; Vera J Comput Biol Chem; 2009 Aug; 33(4):312-24. PubMed ID: 19660986 [TBL] [Abstract][Full Text] [Related]
24. Phosphatidic acid potentiates G(alpha)q stimulation of phospholipase C-beta1 signaling. Litosch I Biochem Biophys Res Commun; 2009 Dec; 390(3):603-7. PubMed ID: 19818737 [TBL] [Abstract][Full Text] [Related]
32. Construction of mutant TKGFP for real-time imaging of temporal dynamics of HIF-1 signal transduction activity mediated by hypoxia and reoxygenation in tumors in living mice. Hsieh CH; Kuo JW; Lee YJ; Chang CW; Gelovani JG; Liu RS J Nucl Med; 2009 Dec; 50(12):2049-57. PubMed ID: 19910419 [TBL] [Abstract][Full Text] [Related]
34. Urotensin II induces rat cardiomyocyte hypertrophy via the transient oxidization of Src homology 2-containing tyrosine phosphatase and transactivation of epidermal growth factor receptor. Liu JC; Chen CH; Chen JJ; Cheng TH Mol Pharmacol; 2009 Dec; 76(6):1186-95. PubMed ID: 19755521 [TBL] [Abstract][Full Text] [Related]
35. The myeloproliferative neoplasms: insights into molecular pathogenesis and changes in WHO classification and criteria for diagnosis. Anastasi J Hematol Oncol Clin North Am; 2009 Aug; 23(4):693-708. PubMed ID: 19577165 [TBL] [Abstract][Full Text] [Related]
36. Gamma-aminobutyric acid transporter 1 negatively regulates T cell activation and survival through protein kinase C-dependent signaling pathways. Wang Y; Luo Q; Xu Y; Feng D; Fei J; Cheng Q; Xu L J Immunol; 2009 Sep; 183(5):3488-95. PubMed ID: 19667098 [TBL] [Abstract][Full Text] [Related]
37. Genetic background modulates susceptibility to oncogen-driven proliferation and lymphoma occurrence in mice carrying a deregulated c-myc transgene. Vincent-Fabert C; Fiancette R; Truffinet V; Cogné N; Cogné M; Denizot Y Leuk Res; 2009 Nov; 33(11):e203-6. PubMed ID: 19524297 [No Abstract] [Full Text] [Related]
38. Hypercoagulability inhibits monocyte transendothelial migration through protease-activated receptor-1-, phospholipase-Cbeta-, phosphoinositide 3-kinase-, and nitric oxide-dependent signaling in monocytes and promotes plaque stability. Seehaus S; Shahzad K; Kashif M; Vinnikov IA; Schiller M; Wang H; Madhusudhan T; Eckstein V; Bierhaus A; Bea F; Blessing E; Weiler H; Frommhold D; Nawroth PP; Isermann B Circulation; 2009 Sep; 120(9):774-84. PubMed ID: 19687358 [TBL] [Abstract][Full Text] [Related]
39. Improving the pharmacokinetics/pharmacodynamics of prolactin, GH, and their antagonists by fusion to a synthetic albumin-binding peptide. Langenheim JF; Chen WY J Endocrinol; 2009 Dec; 203(3):375-87. PubMed ID: 19770179 [TBL] [Abstract][Full Text] [Related]